Dosimetric effect of set-up error in accelerator-based boron neutron capture therapy for head and neck cancer

Komori Shinya, Hirose Katsumi, Sato Mariko, Takeuchi Akihiko, Kato Ryohei, Motoyanagi Tomoaki, Harada Takaomi, Yamazaki Yuhei, Harada Mayumi, Narita Yuki, Kato Takahiro, Takai Yoshihiro

JOURNAL OF RADIATION RESEARCH   63 ( 4 )   684 - 695   2022.7

Determining a methodology of dosimetric quality assurance for commercially available accelerator-based boron neutron capture therapy system

Hirose Katsumi, Kato Takahiro, Harada Takaomi, Motoyanagi Tomoaki, Tanaka Hiroki, Takeuchi Akihiko, Kato Ryohei, Komori Shinya, Yamazaki Yuhei, Arai Kazuhiro, Kadoya Noriyuki, Sato Mariko, Takai Yoshihiro

JOURNAL OF RADIATION RESEARCH   63 ( 4 )   620 - 635   2022.7

Current status of boron neutron capture therapy

Hirose Katsumi, Sato Mariko, Takai Yoshihiro

ANNALS OF ONCOLOGY   33   S415 - S415   2022.7

Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study

Hirose Katsumi, Sato Mariko, Kato Takahiro, Takayama Kanako, Suzuki Motohisa, Yamaguchi Hisashi, Seto Ichiro, Kikuchi Yasuhiro, Murakami Masao, Takai Yoshihiro

JOURNAL OF RADIATION RESEARCH   63 ( 3 )   393 - 401   2022.5

Complementary killing effect of tirapazamine in combination with radiation therapy on cells with high aldehyde dehydrogenase activity in SAS cell line

Ichise K., Hirose K., Sato M., Komai F., Tanaka M., Fujioka I, Kawaguchi H., Hatayama Y., Takai Y., Aoki M.

INTERNATIONAL JOURNAL OF RADIATION RESEARCH   20 ( 2 )   269 - 276   2022.4

Impact of low iodine density tumor area ratio on the local control of non-small cell lung cancer through stereotactic body radiotherapy

Tanaka Mitsuki, Koji Ichise, Fujioka Ichitaro, Sato Mariko, Hirose Katsumi, Kawaguchi Hideo, Hatayama Yoshiomi, Takai Yoshihiro, Tsushima Eiki, Aoki Masahiko

JOURNAL OF RADIATION RESEARCH   62 ( 3 )   448 - 456   2021.5

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (<SUP>10</SUP>B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Hirose Katsumi, Konno Akiyoshi, Hiratsuka Junichi, Yoshimoto Seiichi, Kato Takahiro, Ono Koji, Otsuki Naoki, Hatazawa Jun, Tanaka Hiroki, Takayama Kanako, Wada Hitoshi, Suzuki Motohisa, Sato Mariko, Yamaguchi Hisashi, Seto Ichiro, Ueki Yuji, Iketani Susumu, Imai Shigeki, Nakamura Tatsuya, Ono Takashi, Endo Hiromasa, Azami Yusuke, Kikuchi Yasuhiro, Murakami Masao, Takai Yoshihiro

RADIOTHERAPY AND ONCOLOGY   155   182 - 187   2021.2

Not Only Hypoxia- but Radiation-Induced Epithelial-Mesenchymal Transition Is Modulated by Hypoxia-Inducible Factor 1 in A549 Lung Cancer Cells

Sato M., Hirose K., Ichise K., Yoshino H., Harada T., Hatayama Y., Kawaguchi H., Tanaka M., Fujioka I, Takai Y., Aoki M.

FOLIA BIOLOGICA   67 ( 2 )   62 - 69   2021

YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells

Harada Takaomi, Hirose Katsumi, Wada Yuki, Sato Mariko, Ichise Koji, Aoki Masahiko, Kato Takahiro, Takeda Ken, Takai Yoshihiro

JOURNAL OF RADIATION RESEARCH   61 ( 4 )   524 - 534   2020.7

Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines

Hazawa Masaharu, Yoshino Hironori, Nakagawa Yuta, Shimizume Reina, Nitta Keisuke, Sato Yoshiaki, Sato Mariko, Wong Richard W., Kashiwakura Ikuo

CANCERS   12 ( 4 )   2020.4

Stereotactic Body Radiotherapy for Lung Tumors: Basic Principles and Clinical Results

Aoki Masahiko, Hatayama Yoshiomi, Kawaguchi Hideo, Sato Mariko, Tanaka Mitsuki, Fujioka Ichitaro, Ichise Koji, Hirose Katsumi, Takai Yoshihiro

Hirosaki Medical Journal   69 ( 1-4 )   1 - 9   2019.3

Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line.

Hiromasa Fujita, Katsumi Hirose, Mariko Sato, Ichitaro Fujioka, Tamaki Fujita, Masahiko Aoki, Yoshihiro Takai

Oncology letters   17 ( 2 )   2431 - 2440   2019.2

Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line

Fujita Hiromasa, Hirose Katsumi, Sato Mariko, Fujioka Ichitaro, Fujita Tamaki, Aoki Masahiko, Takai Yoshihiro

ONCOLOGY LETTERS   17 ( 2 )   2431 - 2440   2019.2

Stereotactic body radio therapy for lung tumors: basic principales and clinical results

Masahiko Aoki, Yoshiomi Hatayama, Hideo Kawaguchi, Mariko Sato, Mitsuki Tanaka, Ichitaro Fujioka, Koji Ichise, Katsumi Hirose, and Yoshihiro Takai

Hirosaki Medical Journal   69 ( 1-4 )   1 - 9   2019

The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.

Katsumi Hirose, Mariko Sato, Yoshiomi Hatayama, Hideo Kawaguchi, Fumio Komai, Makoto Sohma, Hideki Obara, Masashi Suzuki, Mitsuki Tanaka, Ichitaro Fujioka, Koji Ichise, Yoshihiro Takai, Masahiko Aoki

Radiation oncology (London, England)   13 ( 1 )   106 - 106   2018.6

Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.

Yuki Wada, Katsumi Hirose, Takaomi Harada, Mariko Sato, Tsubasa Watanabe, Akira Anbai, Manabu Hashimoto, Yoshihiro Takai

Journal of radiation research   59 ( 2 )   122 - 128   2018.3

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.

Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama, Yoshihiro Takai

Radiation oncology (London, England)   12 ( 1 )   192 - 192   2017.12

Clinical results of accelerated hypofractionated radiotherapy for central-type small lung tumours.

Y Hatayama, M Aoki, H Kawaguchi, K Hirose, M Sato, H Akimoto, M Tanaka, I Fujioka, K Ichise, S Ono, Y Takai

Current oncology (Toronto, Ont.)   24 ( 4 )   e285 - e289   2017.8

Safe and successful birth following pelvic radiotherapy for rectal mucosa-associated lymphoid tissue lymphoma: a case report.

Yoshiomi Hatayama, Masahiko Aoki, Hideo Kawaguchi, Katsumi Hirose, Mariko Sato, Hiroyoshi Akimoto, Mitsuki Tanaka, Ichitaro Fujioka, Shuichi Ono, Yoshihiro Takai

Journal of medical case reports   11 ( 1 )   26 - 26   2017.2

The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.

Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama, Yoshihiro Takai

Japanese journal of radiology   34 ( 11 )   718 - 723   2016.11

Impact of pretreatment whole-tumor perfusion computed tomography and 18F-fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy.

Masahiko Aoki, Hiroyoshi Akimoto, Mariko Sato, Katsumi Hirose, Hideo Kawaguchi, Yoshiomi Hatayama, Hiroko Seino, Shinya Kakehata, Fumiyasu Tsushima, Hiromasa Fujita, Tamaki Fujita, Ichitaro Fujioka, Mitsuki Tanaka, Hiroyuki Miura, Shuichi Ono, Yoshihiro Takai

Journal of radiation research   57 ( 5 )   533 - 540   2016.9

Prognostic impact of average iodine density assessed by dual-energy spectral imaging for predicting lung tumor recurrence after stereotactic body radiotherapy.

Masahiko Aoki, Katsumi Hirose, Mariko Sato, Hiroyoshi Akimoto, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Shuichi Ono, Yoshihiro Takai

Journal of radiation research   2016.1

Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.

Masahiko Aoki, Yoshiomi Hatayama, Hideo Kawaguchi, Katsumi Hirose, Mariko Sato, Hiroyoshi Akimoto, Hiroyuki Miura, Shuichi Ono, Yoshihiro Takai

Journal of radiation research   57 ( 1 )   55 - 61   2016.1

Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules.

Masahiko Aoki, Yoshiomi Hatayama, Hideo Kawaguchi, Katsumi Hirose, Mariko Sato, Hiroyoshi Akimoto, Ichitaro Fujioka, Shuichi Ono, Eiki Tsushima, Yoshihiro Takai

Radiation oncology (London, England)   11 ( 1 )   5 - 5   2016

LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells.

Mariko Sato, Katsumi Hirose, Ikuo Kashiwakura, Masahiko Aoki, Hideo Kawaguchi, Yoshiomi Hatayama, Hiroyoshi Akimoto, Yuichiro Narita, Yoshihiro Takai

Molecular medicine reports   12 ( 3 )   3462 - 3468   2015.9

Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.

Masahiko Aoki, Mariko Sato, Katsumi Hirose, Hiroyoshi Akimoto, Hideo Kawaguchi, Yoshiomi Hatayama, Shuichi Ono, Yoshihiro Takai

Radiation oncology (London, England)   10   99 - 99   2015

Correlation between tumor size and blood volume in lung tumors: a prospective study on dual-energy gemstone spectral CT imaging.

Masahiko Aoki, Yoshihiro Takai, Yuichiro Narita, Katsumi Hirose, Mariko Sato, Hiroyoshi Akimoto, Hideo Kawaguchi, Yoshiomi Hatayama, Hiroyuki Miura, Shuichi Ono

Journal of radiation research   55 ( 5 )   917 - 923   2014.9

Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities.

Hiroyuki Miura, Shuichi Ono, Koichi Shibutani, Hiroko Seino, Fumiyasu Tsushima, Shinya Kakehata, Katsumi Hirose, Hiromasa Fujita, Akihisa Kakuta, Masahiko Aoki, Yoshiomi Hatayma, Hideo Kawaguchi, Mariko Sato, Yoshihiro Takai, Takahide Kaneko, Daisuke Sawamura

SpringerPlus   3   625 - 625   2014

Impact of dexamethasone, etoposide, ifosfamide and carboplatin as concurrent chemoradiotherapy agents for nasal natural killer/T-cell lymphoma.

Yoshiomi Hatayama, Masahiko Aoki, Hideo Kawaguchi, Yuichiro Narita, Katsumi Hirose, Mariko Sato, Yoshihiro Takai

Molecular and clinical oncology   1 ( 4 )   680 - 684   2013.7

Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate.

Katsumi Hirose, Satoru Monzen, Haruka Sato, Mariko Sato, Masahiko Aoki, Yoshiomi Hatayama, Hideo Kawaguchi, Yuichiro Narita, Yoshihiro Takai, Ikuo Kashiwakura

Journal of radiation research   54 ( 3 )   438 - 446   2013.5

Effects of radiation on the maturation of megakaryocytes.

Katsumi Hirose, Satoru Monzen, Hironori Yoshino, Haruka Sato, Masahiko Aoki, Yoshiomi Hatayama, Hideo Kawaguchi, Mariko Sato, Yuichiro Narita, Yoshihiro Takai, Ikuo Kashiwakura

Journal of radiation research   54 ( 3 )   447 - 452   2013.5

Improving Uncertainty of Prostate Positioning by Using Implanted Fiducial Marker-Based Hybrid Evaluation Combined with KV Portal Imaging and CBCT for Prostate IMRT

K. Hirose, M. Sato, H. Kawaguchi, M. Aoki, H. Akimoto,Y. Hatayama, F. Komai, M. Souma, H. Obara, M. Suzuki, Y. Takai

Medical Physics   42 ( 6 )   3272   2015